Mite allergen control with acaricide fails

Area of Science:

• Allergen immunotherapy and environmental control
• Pulmonary medicine and asthma management
• Environmental health and toxicology

Background:

• House dust mites are a common allergen triggering asthma exacerbations.
• Effective environmental control strategies are crucial for managing allergic asthma.
• Benzyl benzoate is an acaricide investigated for its potential to reduce mite allergen levels.

Purpose of the Study:

• To evaluate the efficacy of benzyl benzoate powder compared to baking soda in reducing house dust mite allergen levels.
• To assess the impact of these treatments on lung function and asthma medication requirements in adult patients.
• To determine if standard application protocols for benzyl benzoate are effective in an indoor environment.

Main Methods:

• A randomized, double-blind, placebo-controlled trial involving 12 adult asthma patients.
• Carpet application of benzyl benzoate or baking soda at baseline and 6 months.
• Monitoring of Der p I and Der f I allergen levels in dust samples over 12 months.
• Regular spirometry and peak flow rate measurements to assess lung function.

Main Results:

• No significant differences in mean house dust mite allergen levels were observed between benzyl benzoate and baking soda groups.
• No significant improvements in lung function parameters were detected in either treatment group.
• Asthma medication use remained unchanged in both the benzyl benzoate and control groups throughout the study period.

Conclusions:

• Standard application of benzyl benzoate powder to carpets may not effectively reduce house dust mite allergen levels.
• Current application guidelines may be insufficient for achieving clinical benefits in asthma patients.
• Further investigation is warranted to explore alternative application methods, frequencies, and durations for benzyl benzoate efficacy.